[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
    "summary": "Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=14d607e151e25a29a82f823be5046455ee9fe774c0cdf93fe13f786ff60d7d6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741816819,
      "headline": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
      "id": 133185496,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=14d607e151e25a29a82f823be5046455ee9fe774c0cdf93fe13f786ff60d7d6e"
    }
  },
  {
    "ts": null,
    "headline": "Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds",
    "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
    "url": "https://finnhub.io/api/news?id=4ef96eb4da1962efe1167a26ed59efc02c814b69418999e924e1168bd84595da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741804171,
      "headline": "Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds",
      "id": 133185497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
      "url": "https://finnhub.io/api/news?id=4ef96eb4da1962efe1167a26ed59efc02c814b69418999e924e1168bd84595da"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=1db59ec735d9e4102cf6bcd1e6e74065833e8d525dffd36649441a9e01a9234c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741797420,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 133172976,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=1db59ec735d9e4102cf6bcd1e6e74065833e8d525dffd36649441a9e01a9234c"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
    "summary": "Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=f297b0f96ecf5627c1bb5d0f1adf3831195761050b8de52bda165ebfa870c982",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741793414,
      "headline": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
      "id": 133185498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=f297b0f96ecf5627c1bb5d0f1adf3831195761050b8de52bda165ebfa870c982"
    }
  },
  {
    "ts": null,
    "headline": "Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?",
    "summary": "Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, U.S. stocks rose, closing up a robust 2024. The Fund (Investor Shares) surged 0.28% (net of fees) in the quarter underperforming the S&P 500 Index’s […]",
    "url": "https://finnhub.io/api/news?id=45a637544b4f90f35ce141fb273d70eca4a00e8b5a79077c6761d3ad50d5a2c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741784276,
      "headline": "Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?",
      "id": 133185499,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, U.S. stocks rose, closing up a robust 2024. The Fund (Investor Shares) surged 0.28% (net of fees) in the quarter underperforming the S&P 500 Index’s […]",
      "url": "https://finnhub.io/api/news?id=45a637544b4f90f35ce141fb273d70eca4a00e8b5a79077c6761d3ad50d5a2c5"
    }
  }
]